Neurocrine Biosciences (NBIX) Accounts Payables (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Accounts Payables of $808.3 million for Q2 2026, up 65.1% from $489.5 million a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences posted Accounts Payables of $674.3 million, up 46.1% from FY2024.
- Accounts Payables has increased for 12 consecutive years, with a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
- By year, Accounts Payables came in at $461.6 million in FY2024 (+2.9%), $448.8 million in FY2023 (+29.1%), $347.6 million in FY2022 (+53.9%) and $225.8 million in FY2021 (+33.8%).
- The Q2 2026 figure ranks as the highest quarterly Accounts Payables in data going back to Q4 2010.
- Year over year, Accounts Payables has now increased in each of the last seven quarters, with growth averaging 31.8% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q3 2023 (growth of 68.9%); the low point was Q3 2024 (a decline of 21.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $773 million (Q1 2026), $674.3 million (Q4 2025) and $584.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 808.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 808.30 Mn |
| Mar 31, 2026 | 773.00 Mn |
| Dec 31, 2025 | 674.30 Mn |
| Sep 30, 2025 | 584.30 Mn |
| Jun 30, 2025 | 489.50 Mn |
| Mar 31, 2025 | 475.20 Mn |
| Dec 31, 2024 | 461.60 Mn |
| Sep 30, 2024 | 392.70 Mn |
| Jun 30, 2024 | 358.50 Mn |
| Mar 31, 2024 | 417.20 Mn |
| Dec 31, 2023 | 448.80 Mn |
| Sep 30, 2023 | 503.00 Mn |
| Jun 30, 2023 | 391.60 Mn |
| Mar 31, 2023 | 355.70 Mn |
| Dec 31, 2022 | 347.60 Mn |
| Sep 30, 2022 | 297.80 Mn |
| Jun 30, 2022 | 265.70 Mn |
| Mar 31, 2022 | 235.90 Mn |
| Dec 31, 2021 | 225.80 Mn |
| Sep 30, 2021 | 205.90 Mn |
API Access
Neurocrine Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();